Literature DB >> 8000976

Complications of first craniotomy for intra-axial brain tumour.

A M Cabantog1, M Bernstein.   

Abstract

Complications were examined in a single surgeon's series of 207 consecutive adult patients undergoing first craniotomy for intra-axial brain tumour. The study group consisted of 114 gliomas, 74 metastatic tumours and 19 miscellaneous lesions. There were 25 infratentorial tumours and 182 supratentorial tumours (39 deep and 143 superficial). The total number of patients sustaining complications was 52 for an overall complication rate of 25.1%; the rate was higher for infratentorial tumours (44.0%) than supratentorial tumours (22.8%) regardless of histology (p = 0.012). There were 5 deaths for a mortality rate of 2.4%. Forty-seven patients incurred operative morbidity (22.7%); 7 out of the 47 had multiple complications. Sixteen patients sustained transient worsening due to edema (7.7%) and 6 patients sustained permanent neurological deficit (2.9%). Medical complications were suffered by 17 patients (8.2%). Major complications which significantly altered the quality and/or quantity of survival were suffered by 9 patients overall (4.3%).

Entities:  

Mesh:

Year:  1994        PMID: 8000976     DOI: 10.1017/s0317167100041184

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  17 in total

1.  Overview: Brain tumour diagnosis and management/Royal College of Physicians guidelines.

Authors:  R Grant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

2.  Dual-mode IVUS catheter for intracranial image-guided hyperthermia: feasibility study.

Authors:  Carl D Herickhoff; Gerald A Grant; Gavin W Britz; Stephen W Smith
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-11       Impact factor: 2.725

3.  Outcome prediction in intracranial tumor surgery: the National Surgical Quality Improvement Program 2005-2010.

Authors:  Kimon Bekelis; Samuel F Bakhoum; Atman Desai; Todd A Mackenzie; David W Roberts
Journal:  J Neurooncol       Date:  2013-02-24       Impact factor: 4.130

4.  Non-routine discharge disposition is associated with post-discharge complications and 30-day readmissions following craniotomy for brain tumor resection.

Authors:  Nikita Lakomkin; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2017-12-05       Impact factor: 4.130

Review 5.  The role of surgery in low grade gliomas.

Authors:  J Bampoe; M Bernstein
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

6.  Institutional charges and disparities in outpatient brain biopsies in four US States: the State Ambulatory Database (SASD).

Authors:  Kimon Bekelis; Symeon Missios; David W Roberts
Journal:  J Neurooncol       Date:  2013-11       Impact factor: 4.130

7.  Dual-mode IVUS transducer for image-guided brain therapy: preliminary experiments.

Authors:  Carl D Herickhoff; Christy M Wilson; Gerald A Grant; Gavin W Britz; Edward D Light; Mark L Palmeri; Patrick D Wolf; Stephen W Smith
Journal:  Ultrasound Med Biol       Date:  2011-08-19       Impact factor: 2.998

Review 8.  Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis.

Authors:  Saleh A Almenawer; Jetan H Badhiwala; Waleed Alhazzani; Jeffrey Greenspoon; Forough Farrokhyar; Blake Yarascavitch; Almunder Algird; Edward Kachur; Aleksa Cenic; Waseem Sharieff; Paula Klurfan; Thorsteinn Gunnarsson; Olufemi Ajani; Kesava Reddy; Sheila K Singh; Naresh K Murty
Journal:  Neuro Oncol       Date:  2015-01-03       Impact factor: 12.300

9.  Intracranial dual-mode IVUS and hyperthermia using circular arrays: preliminary experiments.

Authors:  Vivek Patel; Edward Light; Carl Herickhoff; Gerald Grant; Gavin Britz; Christy Wilson; Mark Palmeri; Stephen Smith
Journal:  Ultrason Imaging       Date:  2013-01       Impact factor: 1.578

10.  The history of ependymoma management.

Authors:  Kyu-Won Shim; Dong-Seok Kim; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2009-05-21       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.